Abstract | BACKGROUND: OBSERVATIONS: Both patients responded well to monthly doses of intravenous cyclophosphamide with rapid decrease in the frequency and severity of blistering, resulting in resolution of their disease after 7 and 10 months, respectively. CONCLUSIONS:
|
Authors | A G Pandya, R D Sontheimer |
Journal | Archives of dermatology
(Arch Dermatol)
Vol. 128
Issue 12
Pg. 1626-30
(Dec 1992)
ISSN: 0003-987X [Print] United States |
PMID | 1456758
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Cyclophosphamide
(administration & dosage)
- Drug Administration Schedule
- Female
- Humans
- Infusions, Intravenous
- Male
- Pemphigus
(drug therapy)
|